Stereotaxis Overview
- Year Founded
-
1990
- Status
-
Public
- Employees
-
131
- Stock Symbol
-
STXS
- Investments
-
2
- Share Price
-
$0.85
- (As of Thursday Closing)
Stereotaxis General Information
Description
Stereotaxis Inc is engaged in robotic technologies designed to enhance the treatment of arrhythmias and perform endovascular procedures. The company's mission is the discovery, development, and delivery of robotic systems, instruments, and information solutions for the interventional laboratory. These innovations help physicians provide patient care with robotic precision and safety, improved lab efficiency and productivity, and enhanced integration of procedural information. The company's revenue generation is derived from the streams of Systems, Disposables, Royalty, and Sublease, of which a majority of revenue is generated from the Disposables, service, and accessories stream.
Contact Information
Website
www.stereotaxis.comCorporate Office
- 710 North Tucker Boulevard
- Suite 110
- Saint Louis, MO 63101
- United States
Corporate Office
- 710 North Tucker Boulevard
- Suite 110
- Saint Louis, MO 63101
- United States
Stereotaxis Stock Performance
As of 12-Nov-2026, Stereotaxis’s stock price is $0.85. Its current market cap is $85.7M with 101M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $0.85 | $0.90 | $0.80 - $2.86 | $85.7M | 101M | 663K | -$0.24 |
Stereotaxis Financials Summary
As of 30-Sep-2026, Stereotaxis has a trailing 12-month revenue of $31.5M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 123,165 | 214,992 | 194,063 | 130,617 |
| Revenue | 31,528 | 32,377 | 26,918 | 26,771 |
| EBITDA | (20,555) | (23,770) | (21,214) | |
| Net Income | (22,342) | (21,643) | (24,045) | (20,713) |
| Total Assets | 82,112 | 52,251 | 46,724 | 41,909 |
| Total Debt | 7,910 | 5,436 | 6,006 | 5,490 |
Stereotaxis Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Stereotaxis Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
Stereotaxis Comparisons
Industry
Financing
Details
Stereotaxis Competitors (12)
One of Stereotaxis’s 12 competitors is Atricure, a Formerly VC-backed company based in Mason, OH.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Atricure | Formerly VC-backed | Mason, OH | ||||
| Medrobotics | Formerly VC-backed | Raynham, MA | ||||
| Angiodynamics | Corporation | Latham, NY | ||||
| Moon Surgical | Venture Capital-Backed | Paris, France | ||||
| New View Medical | Venture Capital-Backed | Andover, MA |
Stereotaxis Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Stereotaxis Patents
Stereotaxis Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| EP-4395676-A1 | Drawn filled tubing magnets, and methods, devices, and systems related thereto | Active | 01-Sep-2021 | ||
| US-20230071158-A1 | Drawn filled tubing magnets, and methods, devices, and systems related thereto | Active | 01-Sep-2021 | ||
| WO-2023034887-A1 | Drawn filled tubing magnets, and methods, devices, and systems related thereto | Inactive | 01-Sep-2021 | ||
| US-12653989-B2 | Method for manufacturing a magnet and systems and devices including a magnet | Active | 01-Sep-2021 | ||
| EP-4395676-B1 | Method of forming a drawn tubing magnet | Active | 01-Sep-2021 | A61M25/0158 |
Stereotaxis Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Stereotaxis Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Stereotaxis Acquisitions (2)
Stereotaxis’s most recent deal was a Merger/Acquisition with Robocath. The deal was made on 09-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Robocath | 09-Jul-2026 | Merger/Acquisition | Surgical Devices | ||
| Access Point Technologies | 31-Jul-2024 | Merger/Acquisition | Therapeutic Devices |
Stereotaxis ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
34.16 | High Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,585
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
Stereotaxis Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Robocath | Rouen, France | 2009 |
Stereotaxis FAQs
-
When was Stereotaxis founded?
Stereotaxis was founded in 1990.
-
Where is Stereotaxis headquartered?
Stereotaxis is headquartered in Saint Louis, MO.
-
What is the size of Stereotaxis?
Stereotaxis has 131 total employees.
-
What industry is Stereotaxis in?
Stereotaxis’s primary industry is Surgical Devices.
-
Is Stereotaxis a private or public company?
Stereotaxis is a Public company.
-
What is Stereotaxis’s stock symbol?
The ticker symbol for Stereotaxis is STXS.
-
What is the current stock price of Stereotaxis?
As of 12-Nov-2026 the stock price of Stereotaxis is $0.85.
-
What is the current market cap of Stereotaxis?
The current market capitalization of Stereotaxis is $85.7M.
-
What is Stereotaxis’s current revenue?
The trailing twelve month revenue for Stereotaxis is $31.5M.
-
Who are Stereotaxis’s competitors?
Atricure, Medrobotics, Angiodynamics, Moon Surgical, and New View Medical are some of the 12 competitors of Stereotaxis.
-
What is Stereotaxis’s annual earnings per share (EPS)?
Stereotaxis’s EPS for 12 months was -$0.24.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
